Isolation and characterization of the promoter of the human GABAA receptor alpha 1 subunit gene

J Neurochem. 1994 Apr;62(4):1643-6.

Abstract

The GABAA receptor, as assessed by ligand binding and chloride flux measurement in vivo and in vitro, is down-regulated in response to chronic benzodiazepine exposure. The mRNA levels of the alpha 1 and gamma 2 subunits of the receptor are also reduced. We have isolated the promoter of the gene encoding the alpha 1 subunit of the GABAA receptor to elucidate the regulatory mechanism of its expression. A DNA segment 650 bp long has been isolated that includes 151 bp of untranslated 5' end of the cDNA sequence and 500 bp of potential promoter-enhancer region. The transcriptional activity of this DNA segment linked to the firefly luciferase gene showed a strong orientation specificity. The promoter activity was localized to a 60-bp segment by deletion mapping. Mobility shift binding assay results suggest that this segment may interact with one or more factors in HeLa cell nuclear extracts to form a transcriptional complex. Primary cultures of embryonic chick cortical cells transfected with the promoter-luciferase construct were treated chronically with lorazepam. Transcriptional activity of this promoter construct was strongly repressed by chronic administration of lorazepam.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Cerebral Cortex / metabolism
  • Chick Embryo
  • Clonazepam / pharmacology
  • DNA / chemistry
  • DNA / genetics
  • DNA / isolation & purification*
  • DNA, Complementary / chemistry
  • Enhancer Elements, Genetic
  • HeLa Cells
  • Humans
  • Luciferases / genetics
  • Molecular Sequence Data
  • Promoter Regions, Genetic*
  • Receptors, GABA / genetics*
  • Regulatory Sequences, Nucleic Acid
  • Transcription, Genetic
  • Transfection

Substances

  • DNA, Complementary
  • Receptors, GABA
  • Clonazepam
  • DNA
  • Luciferases

Associated data

  • GENBANK/S69334